Ibuprofen vs naproxen.
Choosing between these two is rarely about potency, because at equivalent doses they do much the same thing. It is about how long each one lasts and which risk you are most trying to avoid in the patient in front of you.
Both are non-selective COX inhibitors, and the difference is duration: ibuprofen has a half-life of about two hours and is taken three or four times daily, while naproxen lasts around fourteen hours and is taken twice daily. Naproxen also appears to carry the lowest cardiovascular risk of the non-selective NSAIDs.
Ibuprofen vs Naproxen at a glance
| Property | Ibuprofen | Naproxen |
|---|---|---|
| COX selectivity | Non-selective | Non-selective |
| Half-life | About 2 hours | About 12 to 17 hours |
| Dosing | Three or four times daily | Twice daily |
| Cardiovascular risk | Higher at anti-inflammatory doses | Lowest among non-selective NSAIDs |
| GI risk | Lower at low doses | Higher, partly from longer exposure |
| Aspirin interaction | Can block aspirin cardioprotection | Similar concern, less studied |
Why duration drives the choice
A short half-life is useful when pain is intermittent and a nuisance when it is constant, because the patient must remember four doses a day to keep a steady effect. Naproxen covers a day in two doses, which suits inflammatory conditions where continuous suppression matters. The same property means a naproxen side effect also persists longer once it appears.
Why naproxen looks safer for the heart
NSAID cardiovascular risk is thought to reflect the balance between inhibiting prostacyclin in the endothelium and thromboxane in platelets. Naproxen produces a relatively sustained platelet effect across the dosing interval, which may offset the endothelial effect, and observational and trial data have consistently placed it at the lower end of cardiovascular risk. This is a class comparison rather than a guarantee of safety.
What neither of them avoids
Both inhibit COX-1 in the gastric mucosa, reducing the prostaglandins that maintain mucus and bicarbonate, and both reduce the prostaglandin-mediated dilation of the afferent arteriole in the kidney. Neither is safe in active peptic ulceration, in significant renal impairment, or alongside an ACE inhibitor and a diuretic together.
Which one would the question pick?
Exams rarely ask what a drug does. They describe a patient and ask which of the two you would choose, so the scenarios below matter more than either drug monograph.
| Scenario | Pick | Why |
|---|---|---|
| Short-lived pain, occasional use | Ibuprofen | Short half-life means the drug clears quickly once it is no longer needed. |
| Inflammatory arthritis needing constant cover | Naproxen | Twice daily dosing maintains continuous suppression. |
| Higher cardiovascular risk patient | Naproxen | Lowest cardiovascular risk among non-selective NSAIDs. |
| Higher GI risk patient | Ibuprofen at the lowest effective dose | Shorter exposure, with gastroprotection considered. |
Traps that catch people on this pair
Assuming one NSAID is simply safer
The risks trade against each other: the agent with the lower cardiovascular risk carries a higher GI risk, so the choice depends on which risk dominates.
Overlooking the triple whammy
An NSAID with an ACE inhibitor and a diuretic is a recognised cause of acute kidney injury, whichever NSAID is used.
Common questions
What is the difference between ibuprofen and naproxen?
Both are non-selective COX inhibitors, and the difference is duration: ibuprofen has a half-life of about two hours and is taken three or four times daily, while naproxen lasts around fourteen hours and is taken twice daily. Naproxen also appears to carry the lowest cardiovascular risk of the non-selective NSAIDs.
What is the difference between ibuprofen and naproxen?
Both are non-selective COX inhibitors. Ibuprofen has a short half-life and is taken three or four times daily; naproxen lasts far longer and is taken twice daily, which suits conditions needing continuous cover.
Which NSAID is safest for the heart?
Among the non-selective NSAIDs, naproxen is consistently placed at the lower end of cardiovascular risk. That is a relative comparison rather than an assurance of safety.
Can NSAIDs damage the kidneys?
Yes. They reduce prostaglandin-mediated dilation of the afferent arteriole, which lowers filtration pressure. The risk is highest when combined with an ACE inhibitor and a diuretic.
Go deeper on the mechanism
A comparison only sticks once the shared mechanism underneath it does, because what separates two drugs is always a variation on something they have in common.
- Cardiovascular pharmacology questions — test the distinction under time
- When to avoid NSAIDs
Other comparisons
Heparin vs Warfarin · Warfarin vs DOACs · Unfractionated heparin vs Enoxaparin · Propranolol vs Atenolol · Metoprolol vs Atenolol · Amlodipine vs Nifedipine · Furosemide vs Bendroflumethiazide · Spironolactone vs Eplerenone · All comparisons
Study aid only. This page is written for learning and examination practice. It is not medical advice, not clinical decision support, and must never be used to make a decision about a real patient. Always verify against your local formulary, the product literature and a qualified pharmacist. See our medical disclaimer.
Two drugs, one property apart.
PharmBit teaches the shared mechanism first, then the single difference that splits the pair. Free download, no credit card.
Free to download. 7-day Pro trial. Cancel anytime.